Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Hair loss in women may have causes other than hormones.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

A 3-month stay in space causes skin thinning, disrupts hair growth, and changes muscle-related genes in mice.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Blood tests confirmed a baby in the womb had a CMV infection.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Two patients with porphyria cutanea tarda experienced their grey hair turning dark again.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Lipedematous scalp is mainly caused by an increase in fat tissue under the skin and is different from lipedematous alopecia.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Early hair loss may indicate prostate issues.

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

AR gene not major factor in female hair loss; different from male hair loss.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.